bpc 157 gastric juice BPC-157 ORAL BPC-157 | High Purity (Laboratory

Reading Each Dose on the Ladder Trial and clinical protocols seek the lowest dose that keeps the relevant markers moving without unacceptable side effects

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

This helps improve blood flow to muscles during and after activity, delivering more oxygen and clearing out metabolic waste

more commonly, shifts accumulate over months as the body adjusts